| Financial Year |
March 31 2023 |
| Monetary Funds |
829,207,484.29 |
| Held-for-trading Financial Assets |
57,138,420.30 |
| Notes Receivable |
8,188,092.22 |
| Accounts Receivable |
242,559,305.53 |
| Advances to Suppliers |
18,312,126.71 |
| Other Receivables |
3,977,818.37 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
285,454,291.15 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
34,958,289.42 |
| Total Current Assets |
1,488,018,799.81 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
-- |
| Fixed Assetes |
421,767,792.09 |
| Under-construction Projects |
123,109,990.69 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
42,397,540.70 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
1,875,289.83 |
| Deferred Income Tax Assets |
10,078,197.13 |
| Other Non-Current Assets |
1,105,600.00 |
| Sub-Total of Non-Current Assets |
600,334,410.44 |
| Total Assets |
2,088,353,210.25 |
| Short-Term Loans |
41,040,580.53 |
| Trading Financial liabilities |
-- |
| Notes Payable |
2,345,148.81 |
| Accounts Payable |
174,453,019.16 |
| Accounts Received In Advance |
1,051,418.52 |
| Employee Compensation Payable |
25,769,065.99 |
| Taxes Payable |
10,546,188.63 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
14,702,810.70 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
-- |
| Other Current Liabilities |
2,506,893.71 |
| Sub-Total of Current Liabilities |
313,527,126.79 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
3,183,652.29 |
| Total Liabilities |
316,710,779.08 |
| Paid-In Capital(Or Share Stock) |
356,517,053.00 |
| Capital Surplus |
341,475,301.00 |
| Surplus Reserve |
116,251,826.65 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
772,812,617.68 |
| Minority Stockholder's Interest |
184,063,975.10 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,587,578,456.07 |
| Owner's Equity（Stockholder's Equity） |
1,771,642,431.17 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
2,088,353,210.25 |
